CWM
MYGN icon

CIBC World Markets’s Myriad Genetics MYGN Stock Holding History

CIBC World Markets’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$59.6K Sell
11,218
-8,624
-43% -$50.9K ﹤0.01% 1454
2025
Q1 		$176K Buy
+19,842
New +$238K ﹤0.01% 1504

Other funds holding MYGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

CIBC World Markets's MYGN Position: Q2 2025 in Review

CIBC World Markets reduced its Myriad Genetics (MYGN) stake by 43% in Q2 2025, selling an estimated $50.9K and leaving 11,218 shares worth $59.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1454.

CIBC World Markets first reported a position in MYGN in Q1 2025 and has held it in 2 quarters since. The position peaked at $176K in Q1 2025. 221 funds tracked by Wall St. Rank hold MYGN as of Q2 2025.

  • CIBC World Markets held 11,218 shares of Myriad Genetics worth $59.6K as of Q2 2025.
  • CIBC World Markets sold 8,624 Myriad Genetics shares in Q2 2025, an estimated $50.9K.
  • Myriad Genetics made up ﹤0.01% of CIBC World Markets's portfolio in Q2 2025, its #1454 holding.
  • CIBC World Markets first reported a position in Myriad Genetics in Q1 2025 and has held it in 2 quarters since.
  • CIBC World Markets's Myriad Genetics position peaked at $176K in Q1 2025.
  • 221 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2025.

Based on CIBC World Markets's 13F filing for Q2 2025, filed 14 Aug 2025.